𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Accurate quantification of dystrophin mRNA and exon skipping levels in Duchenne Muscular Dystrophy

✍ Scribed by Spitali, Pietro; Heemskerk, Hans; Vossen, Rolf HAM; Ferlini, Alessandra; den Dunnen, Johan T; 't Hoen, Peter AC; Aartsma-Rus, Annemieke

Book ID
109885579
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
292 KB
Volume
90
Category
Article
ISSN
0023-6837

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Theoretic applicability of antisense-med
Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations
✍ Annemieke Aartsma-Rus; Ivo Fokkema; Jan Verschuuren; Ieke Ginjaar; Judith van De πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 176 KB

Antisense-mediated exon skipping aiming for reading frame restoration is currently a promising therapeutic application for Duchenne muscular dystrophy (DMD). This approach is mutation specific, but as the majority of DMD patients have deletions that cluster in hotspot regions, the skipping of a smal

Characterization of a complex Duchenne m
Characterization of a complex Duchenne muscular dystrophy–causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping
✍ Heidi R. Madden; Sue Fletcher; Mark R. Davis; Steve D. Wilton πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 268 KB

Out of three mutations in the dystrophin gene that cause Duchenne muscular dystrophy (DMD), the most common, serious childhood muscle wasting disease, two are genomic deletions of one or more exons that disrupt the reading frame. Specific removal of an exon flanking a genomic deletion using antisens